A drug that boosts bone growth in children with achondroplasia — the most common form of dwarfism — may also reduce their chances of SIDS, sleep apnoea and needing surgery.
A drug that boosts bone growth in children with the most common form of dwarfism, may also reduce their chances of sudden infant death syndrome, sleep apnea and needing surgery, according to a new study.
Bone growth drug may reduce sudden infant death syndrome in children with common form of dwarfism medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
- In the highest dose level (Cohort 5, 0.25 mg/kg once daily), the mean change from baseline in annualized height velocity (AHV) at six months was +3.03.
 Daisy Broadway knows there will always be people against what her and her partner Justin Ebbels are doing for their son Casper. The Melbourne bub was enrolled in a controversial drug trial when he was months old and will receive daily injections until he s 18 and old enough to decide for himself if he wants to continue treatment. The world-first treatment, led by the Murdoch Children s Research Institute, is allowing those with achondroplasia to grow at the same rate as their peers and possibly avoid surgery. Daisy Broadway says theyâre doing what they think is best for Casperâs health.